1. Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan
- Author
-
Oka, Keisuke, Matsumoto, Akane, Tetsuka, Nobuyuki, Morioka, Hiroshi, Iguchi, Mitsutaka, Ishiguro, Nobuhisa, Nagamori, Tsunehisa, Takahashi, Satoshi, Saito, Norihiro, Tokuda, Koichi, Igari, Hidetoshi, Fujikura, Yuji, Kato, Hideaki, Kanai, Shinichiro, Kusama, Fumiko, Iwasaki, Hiromichi, Furuhashi, Kazuki, Baba, Hisashi, Nagao, Miki, Nakanishi, Masaki, Kasahara, Kei, Kakeya, Hiroshi, Chikumi, Hiroki, Ohge, Hiroki, Azuma, Momoyo, Tauchi, Hisamichi, Shimono, Nobuyuki, Hamada, Yohei, Takajo, Ichiro, Nakata, Hirotomo, Kawamura, Hideki, Fujita, Jiro, and Yagi, Tetsuya
- Abstract
•All carbapenemase-producing Enterobacterales (CPE) were IMP-type metallo-β-lactamase-producers.•The Enterobacter cloacaecomplex was predominant in CPE.•Klebsiella aerogenesand the Enterobacter cloacaecomplex were the major species in non–carbapenemase-producing (non-CP) carbapenem-resistant Enterobacterales (CRE).•The 28-day mortality was comparable in both CPE and non-CP CRE groups.•In CRE patients, bloodstream infections, mechanical ventilation, and cancer with metastasis were independent risk factors for 28-day mortality.
- Published
- 2022
- Full Text
- View/download PDF